Zhengye Biotechnology (ZYBT) said late Thursday it received a written notification letter from Nasdaq on May 29 about non-compliance with the minimum bid price requirement for continued listing.
The company said it has been provided 180 calendar days, or until November 25, to regain compliance with Nasdaq listing rule.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.